A glucosiduronic acid resulting from the formal condensation of any substance with beta-D-glucuronic acid to form a glycosidic bond.
ChEBI ID: 15341
| Member | Definition | Role |
|---|---|---|
| 1-hydroxymethylmidazolam glucuronide | A beta-D-glucosiduronic acid that is beta-D-glucuronic acid in which the anomeric hydroxyl hydrogen has been replaced by a 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin-4-yl group. It is the glucuronidated conjugate of the midazolam metabolite, 1-hydroxymidazolam. | 1-hydroxymidazolam beta-D-glucuronide |
| 1-salicylate glucuronide | A beta-D-glucosiduronic acid that is the glucuronide conjugate of salicyclic acid. | 1-salicylate glucuronide |
| 4-methylumbelliferyl glucuronide | A beta-D-glucosiduronic acid having a 4-methylumbelliferyl substituent at the anomeric position. A hyaluronan synthesis inhibitor, it is anti-tumourigenic for various malignant tumours. | 4-methylumbelliferone beta-D-glucuronide |
| 4-nitrophenylglucuronide | A beta-D-glucosiduronic acid having a 4-nitrophenyl substituent at the anomeric position. | 4-nitrophenyl beta-D-glucuronide |
| 7-hydroxycoumarin glucuronide | 7-hydroxycoumarin O(7)-glucosiduronic acid | |
| acetaminophen glucuronide | A beta-D-glucosiduronic acid that is the O-glucuronide of paracetamol (acetaminophen). | acetaminophen O-beta-D-glucosiduronic acid |
| androsterone glucuronide | A steroid glucosiduronic acid having androsterone as the steroid component. | androsterone 3-glucosiduronic acid |
| E3040 glucuronide | A member of the class of benzothiazoles that is E3040 in which the hydroxy hydrogen at position 6 has been replaced by a beta-D-glucosiduronic acid group. It is a metabolite of the anti-inflammatory drug, E3040. | E3040 glucuronide |
| eriodictyol 7-glucuronide | A beta-D-glucosiduronic acid that is the 7-O-glucuronide of (2R)-eriodictyol. Isolated from the flowers of Chrysanthemum indicum, it exhibits inhibitory activity for rat lens aldose reductase. | (2R)-eriodictoyl-7-O-beta-D-glucopyranosiduronic acid |
| estradiol-3-glucuronide | A steroid glucosiduronic acid that consists of 17beta-estradiol having a beta-glucuronyl residue attached at position 3 via a glycosidic linkage. | 17beta-estradiol 3-glucosiduronic acid |
| estriol-16 alpha-glucuronide | A steroid glucosiduronic acid that is estriol in which the phenolic hydrogen has been replaced by a beta-D-glucuronyl residue. | estriol 16-O-(beta-D-glucuronide) |
| estrone-3-glucuronide | The 3-beta-D-glucuronide of estrone. | estrone 3-O-(beta-D-glucuronide) |
| ethyl glucuronide | A beta-D-glucosiduronic acid that is the ethyl derivative of beta-D-glucuronic acid. | ethyl glucuronide |
| glycyrrhetyl 3-monoglucuronide | A triterpenoid saponin that is the 3-O-beta-glucuronide of glycyrrhetic acid. It is a metabolite of glycyrrhizin contained in licorice and potentially a causative agent in the pathogenesis of pseudoaldosteronism. | glycyrrhetic acid 3-O-glucuronide |
| oleanolic acid 3-o-monoglucuronide | oleanolic acid 3-O-beta-D-glucosiduronic acid | |
| oroxylin a-7-o-glucuronide | The glycosyloxyflavone which is the 7-O-glucuronide of oroxylin A. | oroxylin A 7-O-beta-D-glucuronide |
| quercetin 3-o-glucuronide | A quercetin O-glycoside that consists of quercetin attached to a beta-D-glucuronopyranosyl moiety at position 3 via a glycosidic linkage. Isolated from Salvia and Phaseolus vulgaris, it exhibits antioxidant and antidepressant activities. | miquelianin |
| testosterone 17-glucosiduronate | A steroid glucosiduronic that is testosterone carrying a glucosiduronic acid residue at position 17. | testosterone 17-glucosiduronic acid |
| wogonoside | The glycosyloxyflavone which is the 7-O-glucuronide of wogonin. | wogonin 7-O-beta-D-glucuronide |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 168 (13.02) | 18.7374 |
| 1990's | 188 (14.57) | 18.2507 |
| 2000's | 266 (20.62) | 29.6817 |
| 2010's | 539 (41.78) | 24.3611 |
| 2020's | 129 (10.00) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 74 (5.28%) | 5.53% |
| Reviews | 46 (3.28%) | 6.00% |
| Case Studies | 24 (1.71%) | 4.05% |
| Observational | 8 (0.57%) | 0.25% |
| Other | 1,249 (89.15%) | 84.16% |